Disclaimer:AI-generated summaries may contain errors. Verify critical details against primary literature before clinical use.
49 articles
(Search: "lymphoma chemotherapy")Showing 20 on this page
The bottom line
35 new this week · Newest first20 results for “lymphoma chemotherapy”
Oral chemotherapy offers practical alternative to injectable drugs in feline cancer management.
PaperOral chemotherapy agents in cats: clinical uses, administration and side effects.Pre-chemotherapy assessment of L-asparaginase use, CKD status, weight loss, and acidosis identifies ATLS-risk dogs.
PaperA potential risk factor associated with acute tumor lysis syndrome in dogs with multicentric lymphoma receiving chemotherapy.Anti-CD20 antibody with CHOP chemotherapy shows promising results in canine B-cell lymphoma.
PaperAfucosylated anti-canine CD20 antibody combined with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in dogs with B-cell lymphoma.Adnexal lymphoma diagnosis should prompt reevaluation of concurrent intracranial masses for systemic disease.
PaperExtranodal Lymphoma With Adnexal and Suspected Intracranial Involvement in a Dog.Chemotherapy can lead to significant ultrasonographic and clinical improvements in cats with renal lymphoma.
PaperUltrasonographic characteristics of renal lymphoma in cats receiving chemotherapy.Doxorubicin may cause more GI adverse events than epirubicin in canine lymphoma treatment.
PaperIn response to 'Factors associated with the development of gastrointestinal adverse events in dogs with multicentric lymphoma treated with CHOP or CEOP-based protocols: a multi-institutional, retrospective study' by Treggiari et al.Doxorubicin is linked to a higher incidence of GI adverse events than epirubicin in canine lymphoma treatment.
PaperReply to In response to "Factors associated with the development of gastrointestinal adverse events in dogs with multicentric lymphoma treated with CHOP or CEOP-based protocols: a multi-institutional, retrospective study".Doxorubicin is associated with a higher incidence of GI adverse events than epirubicin in canine lymphoma treatment.
PaperFactors associated with the development of gastrointestinal adverse events in dogs with multicentric lymphoma treated with CHOP or CEOP-based protocols: a multi-institutional, retrospective study.Malignant tumors are prevalent in aged, female, purebred dogs, often treated with surgery or chemotherapy.
PaperPet cancer cases and patterns of treatment at a Spanish veterinary teaching hospital: a retrospective study from 2015 to 2024.Combining surgical resection with chemotherapy may significantly improve survival in cats with colorectal lymphoma.
PaperA retrospective descriptive study of colorectal large or intermediate cell lymphoma in cats managed with surgical resection and/or medical management.Neurolymphomatosis is a rare T-cell lymphoma in dogs; CSF analysis is crucial for diagnosis.
PaperNeurolymphomatosis of T-Cell Origin in a Dog.Short-term oral CBD/CBDA-rich hemp supplementation is safe and well-tolerated in dogs undergoing CHOP chemotherapy for lymphoma.
PaperSafety, Efficacy and Doxorubicin Pharmacokinetics During Cannabidiol/Cannabidiolic Acid Rich Hemp Oil Use in Dogs With Lymphoma Undergoing CHOP Chemotherapy.Repeated vincristine administration does not induce thrombocytopenia in cats with lymphoma.
PaperEffect of repeated vincristine administration on platelet count in cats with lymphoma.The COVP chemotherapy protocol is effective and well-tolerated for treating large-cell lymphoma in cats.
PaperUse of Cyclophosphamide, Vincristine, Prednisolone and Vinblastine for the Treatment of Large Cell Lymphoma in Cats.YYSXF may delay chemotherapy-induced myelosuppression in canine lymphoma, requiring larger studies.
PaperEfficacy of Yang Yin Sheng Xue formula against canine lymphoma chemotherapy-induced myelosuppression.rcIL-15 adjuvant to chemotherapy improves lymphoma response and quality of life in dogs.
PaperImmunotherapeutic efficacy of recombinant canine IL-15 as an adjunct to chemotherapy in canine lymphoma.NDV-GFP demonstrates oncolytic activity against feline lymphoma cells in vitro.
PaperOncolytic potential of Newcastle Disease Virus in feline lymphoma cells: an in vitro evaluation.C5-PE38 immunotoxin shows promising preclinical efficacy against canine B-cell lymphoma.
PaperA new treatment for canine B-cell lymphoma based on a recombinant single-domain antibody immunotoxin derived from Pseudomonas aeruginosa exotoxin A.DNA methylation analysis may predict survival in dogs with MHGL.
PaperUse of genome-wide DNA methylation analysis to identify prognostic CpG site markers associated with longer survival time in dogs with multicentric high-grade B-cell lymphoma.The COP-10 protocol provides effective treatment for feline intermediate or large cell lymphoma.
PaperOutcome of treatment with a 10-week COP protocol in cats with intermediate or large cell lymphoma: 27 cases (2014-2023).